IDEXX Labs (IDXX) Misses Q1 EPS by 2c; Adjusts FY13 EPS Outlook

IDEXX Labs (NASDAQ: IDXX) reported Q1 EPS of $0.81, $0.02 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $0 versus the consensus estimate of $341.06 million.

IDEXX Labs sees FY2013 EPS of $3.43-3.46, versus prior guidance of $3.42-3.52 and the consensus of $3.54. IDEXX Labs sees FY2013 revenue of $1.38-1.39 billion, versus the consensus of $1.40 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
• Ecovyst Inc. (ECVT) Tops Q3 EPS by 2c
• Progyny (PGNY) Tops Q3 EPS by 21c ; Offers Guidance